ZAS - About the company
ZAS is an unfunded company based in Bangladesh, founded in 2005. It operates as a Provider of imported pharmaceutical products and temperature controlled distribution services. ZAS has not raised any funding yet. The company has 209 active competitors, including 3 funded and 21 that have exited. Its top competitors include companies like Cardinal Health, Orbital Therapeutics and Swixx BioPharma.
Company Details
Provider of imported pharmaceutical products and temperature controlled distribution services. Operations include the procurement of niche therapeutic molecules and the management of supply chains requiring specific temperature maintenance. The business facilitates the availability of medical treatments through regulated distribution channels and monitors product safety through pharmacovigilance activities.
Key Metrics
Founded Year
2005
Location
Stage
Unfunded
Ranked
48th among 209 active competitors
Employee Count
388 as on Aug 31, 2026
Similar Companies
Sign up to download ZAS's company profile
ZAS's funding and investors
ZAS has not raised any funding rounds yet.
ZAS's founders and board of directors
Founder? Claim ProfileZAS's employee count trend
ZAS has 388 employees as of Aug 26. Here is ZAS's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
ZAS's Competitors and alternates
Top competitors of ZAS include Cardinal Health, Orbital Therapeutics and Swixx BioPharma. Here is the list of Top 10 competitors of ZAS, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Cardinal Health 1971, Dublin (United States), Public | Provider of multiple products and services for healthcare organizations | - | 66/100 | |
2nd | Orbital Therapeutics 2022, Yellow Springs (United States), Acquired | Distributor of RNA medicines | $270M | 55/100 | |
3rd | Swixx BioPharma 2013, Baar (Switzerland), Series C | Provider of sales, funding management and other finance related services catering to Biopharma sector | $54.9M | 51/100 | |
4th | Distributor of speciality drugs | - | 47/100 | ||
5th | FFF Enterprises 1988, Los Angeles (United States), Unfunded | Distributor of specialty dugs | - | - | 44/100 |
6th | Distributor of pharmaceutical products | - | - | 43/100 | |
7th | Harrow 2012, Nashville (United States), Public | Provider of ophthalmic products marketing services | - | 41/100 | |
8th | AlzeCure Pharma 2016, Huddinge (Sweden), Funding Raised | Developer of therapeutics for neurological disorders | - | 41/100 | |
9th | Senderra Rx 2009, Dallas (United States), Late Stage | Distributor of specialty drugs | - | 39/100 | |
10th | Shiv Shivam Pharma 1989, Kolkata (India), Unfunded | Distributor of anticancer drugs | - | - | 39/100 |
48th | ZAS 2005, Bangladesh, Unfunded | Provider of imported pharmaceutical products and temperature controlled distribution services | - | - | 23/100 |
Looking for more details on ZAS's competitors? Click here to see the top ones
ZAS's Investments and acquisitions
ZAS has made no investments or acquisitions yet.
Reports related to ZAS
Here is the latest report on ZAS's sector:
Are you a Founder ?
FAQs about ZAS
Explore our recently published companies
- Mirage Creates - Georgia based, 1997 founded, Unfunded company
- K2-Technology - Modiin based, 2012 founded, Unfunded company
- Benchmark - San Marcos based, 1984 founded, Unfunded company
- Sayre Builders - United States based, Unfunded company
- Al Tamyoz Facility - Qatar based, Unfunded company
- PATRICK ASSARAF - Toronto based, Unfunded company
